Cronos (CRON) Total Non-Current Liabilities (2016 - 2026)
Cronos (CRON) recorded quarterly Total Non-Current Liabilities of $47.5 million in Q1 2026, down 11.04% quarter-over-quarter from $53.4 million in Q4 2025, and up 23.65% on a YoY basis from $38.5 million in Q1 2025.
Cronos (CRON) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends
Cronos' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $47.5 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 23.65% year-over-year to $47.5 million; the TTM figure through Mar 2026 stood at $47.5 million (up 23.65% YoY), while the FY2025 annual figure was $53.4 million, changed N/A from the prior year.
- Total Non-Current Liabilities was $47.5 million for Q1 2026 at Cronos, down from $53.4 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $73.8 million in Q4 2022 to a low of $30.7 million in Q2 2023.
- Historically, Total Non-Current Liabilities has averaged $45.2 million across 5 years, with a median of $45.6 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities slumped 85.45% in 2022, then jumped 59.5% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $73.8 million in 2022, then declined by 12.15% to $64.8 million in 2023, then retreated by 20.42% to $51.6 million in 2024, then gained by 3.62% to $53.4 million in 2025, then declined by 11.04% to $47.5 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $47.5 million (Q1 2026), $53.4 million (Q4 2025), and $45.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.81 Bn |
| 10 | Cronos | 1.06 Bn | 284.85 Mn | 19.15 Mn | 47.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.55 Mn |
| Dec 31, 2025 | 53.45 Mn |
| Sep 30, 2025 | 45.66 Mn |
| Jun 30, 2025 | 44.34 Mn |
| Mar 31, 2025 | 38.45 Mn |
| Sep 30, 2024 | 51.58 Mn |
| Jun 30, 2024 | 34.12 Mn |
| Mar 31, 2024 | 34.72 Mn |
| Dec 31, 2023 | 64.81 Mn |
| Sep 30, 2023 | 32.34 Mn |
| Jun 30, 2023 | 30.65 Mn |
| Mar 31, 2023 | 33.18 Mn |
| Dec 31, 2022 | 73.78 Mn |
| Sep 30, 2022 | 46.23 Mn |
| Jun 30, 2022 | 47.25 Mn |
| Mar 31, 2022 | 45.53 Mn |
| Dec 31, 2021 | 81.59 Mn |
| Sep 30, 2021 | 44.25 Mn |
| Jun 30, 2021 | 208.70 Mn |
| Mar 31, 2021 | 313.00 Mn |